Prognostic performance of 7 biomarkers compared to liver biopsy in early alcohol-related liver diseaseDitlev Nytoft Rasmussen, Maria Kjærgaard, Katrine Prier Lindvig et al.|Journal of Hepatology|2021Cited by 141
Rifaximin-α for liver fibrosis in patients with alcohol-related liver disease (GALA-RIF): a randomised, double-blind, placebo-controlled, phase 2 trialMads Israelsen, Bjørn Stæhr Madsen, Nikolaj Torp et al.|The Lancet. Gastroenterology & hepatology|2023Cited by 74
Sphingolipids Are Depleted in Alcohol-Related Liver FibrosisMaja Thiele, Tommi Suvitaival, Kajetan Trôst et al.|Gastroenterology|2023Cited by 53